IMU 0.00% 10.5¢ imugene limited

Given Leslie's history with Genentech and Axel's current...

  1. 251 Posts.
    lightbulb Created with Sketch. 47
    Given Leslie's history with Genentech and Axel's current position at GSK, which company wins a bidding war here? Would you expect a Roche / Her-Vaxx deal and a PD-1 / GSK deal or would the whole platform more likely go to one company? I wonder what Paul Hopper is aiming for - MERCK? It would seem unlikely to me that GSK would win a HER-Vaxx race as Herceptin is to be trialled with HER-Vaxx and you'd expect Roche to go all out for that should it prove beneficial. How does Axel split his allegiance when that time comes?
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $768.4M
Open High Low Value Volume
10.5¢ 10.8¢ 10.0¢ $746.7K 7.120M

Buyers (Bids)

No. Vol. Price($)
161 9473412 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 259241 4
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
10.3¢
  Change
0.000 ( 2.40 %)
Open High Low Volume
10.3¢ 10.5¢ 10.3¢ 1930285
Last updated 15.59pm 29/03/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.